Chugai Pharmaceutical Co., Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CHGCY | D4S.F | 4552.T | YPH.F | BIIB | RER1.F | |
|---|---|---|---|---|---|---|
| Market cap | 72.80B | 31.06B | 64.55B | 26.36B | 37.61B | 11.00B |
| P/E (TTM) | 22.8 | 20.3 | — | 13.0 | 110.2 | 22.2 |
| Forward P/E | — | 46.1 | 14.4 | — | 15.6 | — |
| Price/book | 5.5 | 3.1 | 1.6 | 2.4 | 2.0 | 5.1 |
| Dividend yield | 3.01% | 3.57% | 3.97% | 3.17% | — | 2.69% |
| 1-year change | −6.23% | −17.43% | −17.24% | +51.13% | +62.35% | +5.27% |
| Today | +2.79% | +5.64% | +4.96% | +5.76% | +2.22% | 0.00% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All CHGCY news ›Chugai Pharmaceutical's net profit rises 23%; lymphoma drug sales remain strong, with potential for full-year forecast upside
Chugai Pharmaceutical saw increased revenue and profit for the January–September 2026 period. While sales of lymphoma treatments and the penetration of new drugs provided support, the profit growth also reflects factors such as…
Chugai Pharmaceutical GAAP EPS of ¥228.07, revenue of ¥1,068B
Chugai Pharmaceutical press release (CHGCF): Q3 GAAP EPS of ¥228.07. Revenue of ¥1068B. - Chugai Pharmaceutical press release (CHGCF): Q3 GAAP EPS of ¥228.07. More on Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q3 2026 Earnings Call Transcript
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q3 2026 Earnings Call October 27, 2026 5:00 AM EDT Kae Miyata - Head of Corporate Communications DepartmentOsamu Okuda - President, CEO & ChairmanTsukasa Kusano - Executive VP and Head of Project &…
Chugai Pharmaceutical Co., Ltd. Stock (4519) - Quote Japan Exchange
CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include…
Analyzing Royalty Pharma (NASDAQ:RPRX) and Chugai Pharmaceutical (OTCMKTS:CHGCY)
Posted by Tristan Rich on Oct 23rd, 2026 Chugai Pharmaceutical (OTCMKTS:CHGCY – Get Free Report) and Royalty Pharma (NASDAQ:RPRX – Get Free Report) are both large-cap healthcare companies, but which is the superior stock? We will compare…
Analyzing Chugai Pharmaceutical (OTCMKTS:CHGCY) & Ascend Wellness (OTCMKTS:AAWH)
Posted by Defense World Staff on Oct 7th, 2026 Chugai Pharmaceutical (OTCMKTS:CHGCY – Get Free Report) and Ascend Wellness (OTCMKTS:AAWH – Get Free Report) are both healthcare companies, but which is the better business? We will compare…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- seekingalpha.com3
- defenseworld.net1
- marketscreener.com1
- note.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.